Literature DB >> 25938748

Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre.

Patrizia Morelli1, Alessandra De Alessandri1, Graziana Manno2, Anna Marchese3, Marta Bassi1, Raffaele Lobello1, Laura Minicucci4, Roberto Bandettini1.   

Abstract

Small colony variant (SCV) Staphylococcus aureus are a subpopulation of auxotroph, slow-growing strains causing persisting and relapsing infections in cystic fibrosis (CF) patients. Twenty-eight SCV and 29 normal S. aureus strains were isolated from 42 out of 222 Italian CF patients. The isolates were characterized for: susceptibility to antibiotics, methicillin-resistance (MR), Panton Valentine leukocidin, auxotrophy, hypermutability and biofilm formation. Clonal identity of SCV and normal strains was determined by pulsed-field gel electrophoresis. We found that 27 out of 28 SCVs were thymidine-dependent. Furthermore, in contrast to normal phenotype, SCVs were characterized by antibiotic resistance. We also found that 39.3% SCV vs 20.7% normal strains were strong mutators. Moreover, SCVs showed a higher capability to form biofilm compared to normal strains (100% vs 59%). Importantly, we found evidence of clonal spread of SCV strain among CF patients. Using molecular typing, we found that five patients shared the same type A and five out of seven MR-SCV belonged to the same clone (Clone C). The particular virulence and spreading ability of MR-SCV observed highlights the importance of accurate identification and susceptibility testing of these strains. It is important to adopt the optimal approach to treat patients and to prevent cross-infection in CF centres.

Entities:  

Keywords:  Antibiotic resistance; Biofilm; Cystic fibrosis; Small colony variants; Staphylococcus aureus; hypermutability

Mesh:

Substances:

Year:  2015        PMID: 25938748

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  5 in total

Review 1.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.

Authors:  Daniel J Wolter; Frankline M Onchiri; Julia Emerson; Mimi R Precit; Michael Lee; Sharon McNamara; Laura Nay; Marcella Blackledge; Ahmet Uluer; David M Orenstein; Michelle Mann; Wynton Hoover; Ronald L Gibson; Jane L Burns; Lucas R Hoffman
Journal:  Lancet Respir Med       Date:  2019-11-11       Impact factor: 30.700

3.  Towards individualized diagnostics of biofilm-associated infections: a case study.

Authors:  Mathias Müsken; Kathi Klimmek; Annette Sauer-Heilborn; Monique Donnert; Ludwig Sedlacek; Sebastian Suerbaum; Susanne Häussler
Journal:  NPJ Biofilms Microbiomes       Date:  2017-09-28       Impact factor: 7.290

4.  A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.

Authors:  Ryan P Trombetta; Paul M Dunman; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  mSphere       Date:  2018-10-31       Impact factor: 4.389

5.  Emergence of Thymidine-Dependent Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Patients in Southern Brazil.

Authors:  Dilair Camargo de Souza; Laura Lucia Cogo; Libera Maria Dalla-Costa; Ana Paula de Oliveira Tomaz; Daniele Conte; Carlos Antonio Riedi; Nelson Augusto Rosario Filho; Jussara Kasuko Palmeiro
Journal:  Microbiol Spectr       Date:  2021-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.